The US International Trade Commission has ended the long-running dispute over blood oxygen monitoring on the Apple Watch. Apple has been in legal hot water with rival Masimo, which claimed to own the patents behind the tech, since it added blood oxygen monitoring to the Apple Watch Series 6 in 2020. The smaller company accused Apple of stealing trade secrets to build the health feature.
Apple managed to have all but two of the 17 patents invalidated in September 2023, but despite that, in December 2023, the U.S. International Trade Commission (ITC) upheld a ruling stating that Apple violated Masimo’s patent, which partially halted sales of the Apple Watch 9 and Apple Watch Ultra 2.
